RAPIDITY OF SYMPTOM IMPROVEMENTS DURING FILGOTINIB INDUCTION THERAPY IN PATIENTS WITH ULCERATIVE COLITIS: POST HOC ANALYSIS OF THE PHASE 2B/3 SELECTION STUDY
Silvio Danese 1
Timothy Ritter 2
Jason Dinoso 3
Jeremy Hsieh 3
Chohee Yun 3
Jie Zhang 4
Sally Zhao
Edward V Loftus Jr
Toshifumi Hibi
Gerhard Rogler
1 Humanitas Clinical and Research Center, IRCCS and Humanitas University,Milan,Italy
2 GI Alliance,Southlake, TX,United States
3 Gilead Sciences, Inc.,Foster City, CA,United States
4 Gilead Sciences, Inc.,Foster City, CA,United States;
Session
IBD drug efficacy and safety
Conference
UEG Week Virtual 2021
Citation
United European Gastroenterology Journal 2021; 9 (Supplement 1)
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]
Social Sharing